IXIARO is a vaccine indicated for active immunization for the prevention of disease caused by Japanese encephalitis virus (JEV) in persons 17 years of age and older.
Menveo is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by serogroups A, C, Y, and W-135. Menveo is approved for use in persons 2 to 55 years of age. Menveo does not prevent serogroup B infections.
RabAvert vaccine is indicated for pre-exposure immunization, in both primary series and booster dose, and for post-exposure prophylaxis against rabies.
BEXSERO® is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO® is approved for use in individuals 10 through 25 years of age. BEXSERO® may not provide protection against all meningococcal serogroup B strains.